Brand Name: RABCOP-L
Generic Name: Rabeprazole Sodium BP & Levosulpiride
Available Strengths:
Rabeprazole Sodium BP 20 mg Levosulpiride (as sustained Release) 30 mg
Rabeprazole & Levosulpiride (SR) Tablets are a combination therapy designed to manage acid-related gastrointestinal disorders and motility issues. Rabeprazole, a proton pump inhibitor, reduces gastric acid secretion, promoting healing of the stomach and esophageal lining, while Levosulpiride, a prokinetic agent, enhances gastric emptying and alleviates bloating, nausea, and postprandial fullness. The sustained-release (SR) formulation ensures long-lasting therapeutic effects and consistent symptom control. Manufactured under strict quality standards, these tablets provide effective relief from gastroesophageal reflux disease (GERD), functional dyspepsia, and related gastrointestinal discomforts. They should be taken only as prescribed by a healthcare professional for optimal results.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com